Leukemia, 0887-6924

Journal

1 - 20 out of 63Page size: 20
Sort by: Type

Publications

  1. Article › Research › Not peer-reviewed
  2. Published

    A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL

    Anna Skowronska, Tatjana Stankovic, 1 Jul 2008, In: Leukemia. 22, 7, p. 1456-1459 4 p.

    Research output: Contribution to journal › Article

  3. Published

    A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin

    Michael Griffiths, 1 Mar 2009, In: Leukemia. 23, 3, p. 614-617 4 p.

    Research output: Contribution to journal › Article

  4. Published

    A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

    Charles Craddock, 2000, In: Leukemia. 14, 11, p. 1954-1959 6 p.

    Research output: Contribution to journal › Article

  5. Published

    Acquired disomy for chromosome 13 is common in AML and associated with FLT3-itd mutations

    Charles Craddock, 20 Oct 2005, In: Leukemia. 19, p. 2355-2358 4 p.

    Research output: Contribution to journal › Article

  6. Published

    An unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL

    Victoria Weston, Tatjana Stankovic, Mark Drayson, 6 Nov 2002, In: Leukemia. 16, 11, p. 2337-2339 3 p.

    Research output: Contribution to journal › Article

  7. Published

    Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype

    Charles Craddock, Michael Griffiths, 1 Oct 2010, In: Leukemia. 24, 10, p. 1817-1821 5 p.

    Research output: Contribution to journal › Article

  8. Published

    Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party

    Keith Wheatley, 2 May 2002, In: Leukemia. 16, 5, p. 776-784 9 p.

    Research output: Contribution to journal › Article

  9. Published

    Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

    Keith Wheatley, 1 Sep 2010, In: Leukemia. 24, 9, p. 1599-1606 8 p.

    Research output: Contribution to journal › Article

  10. Published

    Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage

    Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In: Leukemia. 26, 4, p. 826-830 5 p.

    Research output: Contribution to journal › Article

  11. Published

    Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia.

    Charles Craddock, 1 May 2011, In: Leukemia. 25, 5, p. 808-13 6 p.

    Research output: Contribution to journal › Article

  12. Published

    Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt’s lymphoma cells and cell lines: potential for applying old drugs to a new disease

    John Gordon, Mark Drayson & Christopher Bunce, 1 Mar 2003, In: Leukemia. 17, 3, p. 568-575 8 p.

    Research output: Contribution to journal › Article

  13. Published

    Highly purified CD38(+) and CD38(-) subclones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin

    Dickens Pratt, 1 Jan 2007, In: Leukemia. in press

    Research output: Contribution to journal › Article

  14. Published

    Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

    Charlotte Bradbury, Farhat Khanim, McNeill Hayden, Christopher Bunce, Darren White, Mark Drayson, Charles Craddock & Bryan Turner, 25 Aug 2005, In: Leukemia. 19, 10, p. 1751-1759 9 p.

    Research output: Contribution to journal › Article

  15. Published

    Inappropriate reporting and interpretation of subgroups in the AML-BFM 93 study

    Keith Wheatley & Robert Hills, 1 Nov 2001, In: Leukemia. 15, 11, p. 1803-1804 2 p.

    Research output: Contribution to journal › Article

  16. Published

    Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumour suppressor gene mutations in clonally related composite Hodgkin and non-Hodgkin lymphomas

    Tatjana Stankovic, Belinda Austen, 23 Jun 2005, In: Leukemia. 19, p. 1452-1458 7 p.

    Research output: Contribution to journal › Article

  17. Published

    Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins

    Michael Griffiths, 1 Nov 2003, In: Leukemia. 17, 11, p. 2202-2206 5 p.

    Research output: Contribution to journal › Article

  18. Published

    Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

    Jo Bradwell, 1 Aug 2010, In: Leukemia. 24, 8, p. 1498-1505 8 p.

    Research output: Contribution to journal › Article

  19. Published

    The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome

    Keith Wheatley, 1 Jul 2011, In: Leukemia. 25, 7, p. 1122-1127 6 p.

    Research output: Contribution to journal › Article

  20. Published

    Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2.

    McNeill Hayden, Dickens Pratt, Nick Davies, Farhat Khanim, Mark Drayson & Christopher Bunce, 1 Feb 2009, In: Leukemia. 23, 2, p. 292-304 13 p.

    Research output: Contribution to journal › Article

  21. Published

    Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

    Keith Wheatley, Robert Hills, 1 Dec 2005, In: Leukemia. 19, p. 2130-2138 9 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 Next